|
WO2016161196A1
|
|
Microrna-34 immunotherapy
|
|
US2016151406A1
|
|
Combination cancer therapy with c-met inhibitors and synthetic oligonucleotides
|
|
US2016136181A1
|
|
Microrna dosing regimens
|
|
WO2015131115A1
|
|
Sorafenib-microrna combination therapy for liver cancer
|
|
EP3013975A1
|
|
Biomarkers of mir-34 activity
|
|
US2014308274A1
|
|
Combination cancer treatments utilizing synthetic oligonucleotides and egfr-tki inhibitors
|
|
US2014309278A1
|
|
Combination cancer treatments utilizing micrornas and egfr-tki inhibitors
|
|
AU2012212023A1
|
|
Synthetic mimics of miR-34
|
|
AU2012212105A1
|
|
Synthetic mimics of miR-124
|
|
US2010179213A1
|
|
Methods and Compositions Involving miRNAs In Cancer Stem Cells
|
